Effects of Intragastric Quinine, Alone or Combined With L-isoleucine, on Postprandial Glycaemic Control

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

June 24, 2024

Study Completion Date

June 24, 2024

Conditions
Healthy
Interventions
OTHER

Quinine

Quinine, which is a bitter compound, extracted from the bark of the cinchona tree and has been shown in our previous studies to lower blood glucose in doses of 300-600 mg, will be 'active' in this condition.

OTHER

L-isoleucine

L-isoleucine, which is a branched-chain amino acid, and one of the building blocks of protein, therefore is part of our daily diet, will be 'active' in this condition.

OTHER

Combination of quinine and L-isoleucine

In this condition, both quinine and L-isoleucine will be administered as 'active'.

OTHER

Control

"In the condition, where quinine is 'active', control for L-isoleucine (5 ml oraplus and 95 ml saline) will be administered. In the condition, where L-isoleucine will be 'active', control for quinine (10 ml distilled water) will be administered.~Whereas, in a control condition, both for quinine and L-isoleucine, a control solution will be administered."

Trial Locations (1)

5005

Clinical Research Facility, Adelaide Health and Medical Sciences Building, Adelaide

All Listed Sponsors
lead

University of Adelaide

OTHER